OVERVIEW
The global market for non-invasive prenatal testing (NIPT) is expected to hit USD 8.27 billion by 2025, growing over the projected period at a CAGR of 13.1%. Growth in this market is driven by the high risk of chromosomal abnormalities with an increase in maternal age, increased preference for non-invasive approaches over invasive methods, improved NIPT reimbursement scenario and increased awareness of NIPT.
TABLE OF CONTENT
1 Global Non Invasive Prenatal Testing (NIPT) Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Non Invasive Prenatal Testing (NIPT) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Non Invasive Prenatal Testing (NIPT) Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Non Invasive Prenatal Testing (NIPT) Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Non Invasive Prenatal Testing (NIPT) Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Non Invasive Prenatal Testing (NIPT) Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Non Invasive Prenatal Testing (NIPT) Market – By Product (Market Size – &
million/billion)
8.1 Consumables
8.2 Assay Kits & Reagents
8.3 Disposables
8.4 PCR Instruments
8.5 Microarrays
8.6 Ultrasound Devices
8.7 Other
9 Global Non Invasive Prenatal Testing (NIPT) Market – By Method
9.1 Ultrasound Detection
9.2 Biochemical Screening Tests
9.3 Cell-free DNA in Maternal Plasma Tests
10 Global Non Invasive Prenatal Testing (NIPT) Market – By Application
10.1 Trisomy
10.2 Microdeletion Syndrome
10.3 Other
11 Global Non Invasive Prenatal Testing (NIPT) Market – By End-User
11.1 Diagnostic Laboratories
11.2 Hospitals
12 Global Non Invasive Prenatal Testing (NIPT) Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Non Invasive Prenatal Testing (NIPT) Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Non Invasive Prenatal Testing (NIPT) Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Illumina, Inc.
14.3 Agilent Technologies, Inc.
14.4 Thermo Fisher Scientific, Inc.
14.5 GE Healthcare
14.6 F. Hoffman-La Roche Ltd.
14.7 Perkinelmer, Inc.
14.8 Laboratory Corporation of America Holdings
14.9 Natera, Inc.
14.10 Beijing Genomics Institute
14.11 Yourgene Health
14.12 Company 11 & more
15 Global Non Invasive Prenatal Testing (NIPT) Market – Appendix
15.1 Sources
15.2 Abbreviations